In a recent study, we already identified NFκB-related components of the SASP as major drivers of radioresistance and inhibition of the SASP by the senomorphic drug metformin was found to sensitize HNSCC tumor cells toward irradiation (9). The gene discussed is NFKB1; the disease is neoplasm.